Latest filing published 17 Aug 2026 for Butterfly Network, Inc., €1.8M. Read the official filing
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Larry Robbins, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Butterfly Network, Inc. and CVS HEALTH Corp. We count 29 filings; the first trade dates from 26 May 2021 and the latest from 17 August 2026.
Market trades split into 7 purchases (€8.7M) and 15 sales (€403.5M). Taken together, the sales exceed the purchases by €394.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants. Since January 2026: no purchases and 14 sales on the market.
A typical purchase (the median) is worth €1.4M. Clusters matter here: 2 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 17 August 2026, reports an open-market sale of €1.8M in Butterfly Network, Inc. The last purchase on record was published on 15 December 2025, which is 307 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations